Genetic
Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
Total Trials
1
Max Phase
—
Type
GENETIC
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
1
all time
Status Distribution
Other(1)
Detailed Status
unknown1
Development Timeline
Analytics
Development Status
Total Trials
1
Active
0
Success Rate
N/A
Trials by Status
unknown1100%
Recent Activity
0 active trials
Showing 1 of 1
Clinical Trials (1)
Showing 1 of 1 trials
NCT05763472
Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation
All 1 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 1